Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 3, randomized, double-blind, placebo-controlled, multi-center, efficacy and safety study of imiquimod creams in the treatment of external genital warts.

Trial Profile

A phase 3, randomized, double-blind, placebo-controlled, multi-center, efficacy and safety study of imiquimod creams in the treatment of external genital warts.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 04 Nov 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Genital warts
  • Focus Registrational; Therapeutic Use
  • Sponsors Graceway Pharmaceuticals
  • Most Recent Events

    • 23 May 2011 Additional lead trial sponsor and lead centre (Medicis Pharmaceutical Corporation) and investigator (Jason Wu) identified as reported by ClinicalTrials.gov.
    • 10 Jul 2010 Results from a pooled analysis of phase III trials evaluating the use of imiquimod for the treatment of genital warts have been presented at the Human Papillomavirus Conference, Montreal, 3-8 Jul 2010, according to a Graceway media release.
    • 29 Jan 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top